SCHEMBL1551269

SCHEMBL1551269

N#CCc1ncccc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
MAPT P10636 7/20 0.36
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
APAF1 O14727 1/20 0.34
TDP2 O95551 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CXCR4 P61073 1/20 0.34
LMNA P02545 2/20 0.33
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33
HSP90AA1 P07900 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9656915 0.78 L3MBTL1 (0.41) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL3668845 0.78 ALDH1A1 (0.39) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL2557232 0.78 KDM1A (0.40) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL2890333 0.76 L3MBTL1 (0.59) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL3059867 0.76 ALDH1A1 (0.35) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL30785975 0.76 ALDH1A1 (0.35) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL2001005 0.76 DPP4 (0.42) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL10527716 0.76 HPGD (0.41) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL1625911 0.76 ALDH1A1 (0.35) KDM4EMAPTALDH1A1L3MBTL1MEN1
SCHEMBL31368797 0.76 DPP4 (0.42) KDM4EMAPTALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110130407-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-02 US disclosed
EP-2313391-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. Lundbeck A/S (DK) 2011-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130407-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS KCNQ3, KCNK3, GRIK3 KDM4E 3207/4885MAPT 3860/4885ALDH1A1 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.